These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 59332)
1. Combination chemothereapy with cis-diamminedichloroplatinum (II) and bleomycin in tumors of the head and neck. Wittes RE; Brescia F; Young CW; Magill GB; Golbey RB; Krakoff IH Oncology; 1975; 32(5-6):202-7. PubMed ID: 59332 [TBL] [Abstract][Full Text] [Related]
2. Fatal pulmonary bleomycin toxicity in cisplatin-induced acute renal failure. Bennett WM; Pastore L; Houghton DC Cancer Treat Rep; 1980; 64(8-9):921-4. PubMed ID: 6160913 [TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck. Davis S; Kessler W Cancer Chemother Pharmacol; 1979; 3(1):57-9. PubMed ID: 93988 [No Abstract] [Full Text] [Related]
4. Combination chemotherapy with vinblastine, bleomycin, and cis-diamminedichloroplatinum (II) in squamous cell carcinoma of the head and neck. Brown AW; Blom J; Butler WM; Garcia-Guerrero G; Richardson MF; Henderson RL Cancer; 1980 Jun; 45(11):2830-5. PubMed ID: 6155199 [TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy with cisplatin, bleomycin, and methotrexate in patients with advanced head and neck cancer. Von Hoff DD; Alberts DS; Mattox DE; Coulthard S; Dana B; Manning M; Myers JW; Griffin CB Cancer Clin Trials; 1981; 4(2):215-8. PubMed ID: 6166408 [TBL] [Abstract][Full Text] [Related]
6. Clinical trials of cis-diamminedichloroplatinum (NSC-119875). Lippman AJ; Helson C; Helson L; Krakoff IH Cancer Chemother Rep; 1973 Apr; 57(2):191-200. PubMed ID: 4126381 [No Abstract] [Full Text] [Related]
7. Phase-II study of cis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck. Espana P; Smith F; Abrams J; Haidak D; Ueno W; Woolley P; Schein P Cancer Chemother Pharmacol; 1984; 12(2):98-100. PubMed ID: 6199132 [TBL] [Abstract][Full Text] [Related]
8. Cis-diamminedichloroplatinum (II). A new anticancer drug. Rozencweig M; von Hoff DD; Slavik M; Muggia FM Ann Intern Med; 1977 Jun; 86(6):803-12. PubMed ID: 326117 [TBL] [Abstract][Full Text] [Related]
9. Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy. Randolph VL; Vallejo A; Spiro RH; Shah J; Strong EW; Huvos AG; Wittes RE Cancer; 1978 Feb; 41(2):460-7. PubMed ID: 75760 [TBL] [Abstract][Full Text] [Related]
10. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck. Caradonna R; Paladine W; Ruckdeschel JC; Goldstein JC; Olson JE; Jaski JW; Silvers SA; Hillinger S; Horton J Cancer Treat Rep; 1979 Mar; 63(3):489-91. PubMed ID: 85494 [No Abstract] [Full Text] [Related]
11. [Randomized trial of vincristin-methotrexate-bleomycin and cis-platin or detorubicin for advanced head and neck cancer (author's transl)]. Cappelaere P; Chauvergne J; Klein T; Gary-Bobo J; Guerrin J; Meeus L Bull Cancer; 1981; 68(5):422-7. PubMed ID: 6174165 [TBL] [Abstract][Full Text] [Related]
12. Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatin. Sleijfer S; van der Mark TW; Schraffordt Koops H; Mulder NH Eur J Cancer; 1996 Mar; 32A(3):550-2. PubMed ID: 8814706 [TBL] [Abstract][Full Text] [Related]
13. Advanced male non-seminomatous germ-cell tumours. Combination chemotherapy with cis-platinum, vinblastine and bleomycin. Woods RL; Fox RM; Tattersall MH Med J Aust; 1979 Dec; 2(12):630-2. PubMed ID: 94148 [TBL] [Abstract][Full Text] [Related]
14. [Experiences using combination chemotherapy with cis-platinum, bleomycin and methotrexate in the management of advanced squamous cell carcinomas of the head and neck (author's transl)]. Jahnke V HNO; 1980 Dec; 28(12):405-8. PubMed ID: 6161913 [TBL] [Abstract][Full Text] [Related]
15. Cis-diamminedichloroplatinum (II) by 5-day continuous infusion. A new dose schedule with minimal toxicity. Salem P; Khalyl M; Jabboury K; Hashimi L Cancer; 1984 Feb; 53(4):837-40. PubMed ID: 6537893 [TBL] [Abstract][Full Text] [Related]
16. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate. Amrein PC; Fabian RL Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664 [TBL] [Abstract][Full Text] [Related]
17. cis-Diamminedichloroplatinum(II) alone and in combination in the treatment of testicular and other malignancies. Sarna G; Skinner DG; Smith RB; Zighelboim J; Goodnight JE; Feig S Cancer Treat Rep; 1980; 64(10-11):1077-82. PubMed ID: 7193086 [TBL] [Abstract][Full Text] [Related]
18. Treatment of advanced epidermoid carcinoma of the head and neck using methotrexate, bleomycin and cis-platinum. Orsini MA; Strauss M; Zaino RJ; Messeih AA; Harvey HA; Lipton A Trans Pa Acad Ophthalmol Otolaryngol; 1984; 37(1):71-6. PubMed ID: 6204427 [No Abstract] [Full Text] [Related]
19. Investigational chemotherapeutic agents in head and neck cancer. Rozencweig M; Von Hoff DD; Muggia FM Semin Oncol; 1977 Dec; 4(4):425-9. PubMed ID: 74096 [No Abstract] [Full Text] [Related]
20. Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel. Kovach JS; Moertel CG; Schutt AJ; Reitemeier RG; Hahn RG Cancer Chemother Rep; 1973; 57(3):357-9. PubMed ID: 4584486 [No Abstract] [Full Text] [Related] [Next] [New Search]